Pedro Enrico Ventura

ORCID: 0000-0002-5235-2804
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diagnosis and treatment of tuberculosis
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Salivary Gland Disorders and Functions
  • Renal Diseases and Glomerulopathies
  • Systemic Lupus Erythematosus Research
  • Liver Disease Diagnosis and Treatment
  • Nephrotoxicity and Medicinal Plants
  • Cancer Diagnosis and Treatment
  • Organ Donation and Transplantation
  • Hepatitis C virus research
  • Viral-associated cancers and disorders
  • Renal and Vascular Pathologies
  • Polyomavirus and related diseases
  • Hepatitis B Virus Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Renal Transplantation Outcomes and Treatments

Universidade Federal de Ciências da Saúde de Porto Alegre
2020-2024

Irmandade da Santa Casa de Misericórdia de São Paulo
2023

Abstract Introduction Sjögren’s disease (SD) is an immune-mediated chronic inflammatory that affects epithelial tissues, mainly salivary and lacrimal glands. It also presents extraglandular manifestations. The main renal manifestation tubulointerstitial nephritis (TIN), which can manifest as tubular acidosis (RTA). Urinary citrate may be a biomarker of RTA in these patients. objective this study was to evaluate whether hypocitraturia predictive sample patients with SD tertiary hospital...

10.1186/s42358-024-00387-7 article EN cc-by Advances in Rheumatology 2024-06-03

Kidney shortage for pediatric kidney transplantation (PKT) entails the need to use low-weight and age donors, despite apprehension. The aim of this study was analyze deceased donor transplantations (pDDKT) outcomes in first year after procedure, stratified by age. Retrospective cohort pDDKTs carried out between January 2013, 2018, at a PKT reference hospital Southern Brazil. Donors were divided into group 1 (≤ 6 years), 2 (> years); analysis same period. There 143 pDDKTs; 51 (35.66%) 1; 92...

10.1016/j.jped.2023.07.005 article EN cc-by-nc-nd Jornal de Pediatria 2023-08-14

Introduction: Kidney transplantation in patients with end-stage kidney disease improves quality of life and is associated an increase survival rates. Malignancies are one the three major causes renal recipient´s death a functioning graft after cardiovascular diseases infections. The incidence post-transplant malignancies (PTM) varies between 2.0 30%, depending on characteristics population. Aim study: aim this study to analyze PTM solid organs hematological origin, excluding non-melanoma...

10.1097/01.tp.0000888472.89897.77 article EN Transplantation 2022-09-01

Direct-acting antivirals are the gold-standard treatment for chronic HCV infections, but few studies have investigated their use on kidney and liver transplant recipients. We conducted a real-world study to evaluate rates of sustained virological response with direct-acting in Moreover, it also aimed (DAAs) interference immunosuppressant levels describe frequency adverse events. As part this retrospective observational cohort, we included adult patients that had undergone (KT) or (LT) at our...

10.1590/s1678-9946202365059 article EN Revista do Instituto de Medicina Tropical de São Paulo 2023-01-01

Abstract Introduction: Sjögren's disease (SD) is an immune-mediated chronic inflammatory that affects epithelial tissues, especially salivary and lacrimal glands, as well extra glandular manifestations. The main renal manifestation tubulointerstitial nephritis (TIN), which may present clinically tubular acidosis (RTA). Urinary citrate be early biomarker of RTA in these patients. aim this study was to evaluate whether hypocitraturia a predictive ATR sample patients with SD tertiary hospital...

10.21203/rs.3.rs-3671911/v1 preprint EN cc-by Research Square (Research Square) 2024-02-20

Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI of KT candidates living donors (LD) with their IGRA results, evaluate if this would improve isoniazid (INH) treatment referral.We evaluated adult LD complete QuantiFERON-TB® Gold...

10.1590/2175-8239-jbn-2020-0189 article EN cc-by Brazilian Journal of Nephrology 2021-05-17

Background: Tuberculosis (TB) is an important infectious complication after kidney transplantation (KT). Latent tuberculosis infection (LTI) screening and treatment fundamental to prevent post-transplant active disease. Methods: We described a cohort of adult KT recipients from April 4th, 2014 October 31st, 2018, with follow-up until 2019, regarding pre-transplant LTI posttransplant tuberculosis. Results: There were 986 performed in the study period. 189 positive screening, 488 negative 309...

10.1097/01.tp.0000700464.66830.10 article EN Transplantation 2020-08-28
Coming Soon ...